PVCT — Provectus Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Provectus Biopharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	0.097	0.683	0.022	0.077	0.307
Net Total Accounts Receivable
Net Total Receivables	0.004	0.005	0	0	—
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.424	3.44	1.9	1.36	0.977
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.166	0.071	0.138	0.084	0.029
Net Intangible Assets
Total Assets	0.589	3.51	2.04	1.45	1.01
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	30.7	7.7	8.19	9.02	6.98
Long Term Debt
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Liabilities	30.8	7.7	8.27	9.04	6.97
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-30.2	-4.19	-6.23	-7.59	-5.96
Total Liabilities & Shareholders' Equity	0.589	3.51	2.04	1.45	1.01
Total Common Shares Outstanding
Total Preferred Shares Outstanding